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Background: Peer-reviewed studies suggest that a hostile gestational environment is 
associated with delayed neurological development in infants. Autism spectrum disorder 
(ASD) is estimated to affect 1 in 59 children in the United States; however, few studies have 
specifically investigated risk factors for autism in Hispanic children. Purpose: The 
University of Texas RGV Hispanic Autism Research Center (HARC) studied Hispanic 
children with ASD and their biological mothers to identify potential environmental exposures 
and prenatal risk factors that could impact the risk for ASD through preliminary research in 
the Rio Grande Valley. Methods: This pilot study recruited 25 Hispanic mothers and their 
biological children with autism and 25 Hispanic control mothers and children. Participants 
completed a twelve-section survey that included specific prenatal risk factors, such as 
illnesses and medications taken during pregnancy. The goal was to evaluate if specific 
maternal prenatal risk factors are associated with a higher prevalence of ASD among 
Hispanic children living on the US-Mexico border. Results: Descriptive analysis showed a 
higher proportion of vaginal bleeding and urinary tract infections (UTIs) during gestation in 
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mothers of children with autism than control mothers. We also found evidence of an 
association between ASD in children and mothers who experience vaginal bleeding, UTIs, 
and allergies. No significant inferences can be drawn of maternal medicines taken during 
gestation and ASD in the child. Conclusion: This pilot study adds to the body of research 
suggesting maternal inflammation contributes towards increasing autism risk. The results are 
consistent with peer-reviewed studies that included a varied racial/ethnic study population, 
suggesting no difference in risk factors between Hispanic women and women of other races.  
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BACKGROUND 
 
Literature Review  
Autism 
Autism spectrum disorder (ASD) is a neurodevelopmental disability that can cause 
significant social, communication, and behavioral challenges (CDC, 2018). Symptoms are 
typically detected during childhood and sustain throughout life. The condition was initially 
called “autism”, but identification of the disorder was put on a spectrum in the early 1990s 
when it became apparent that autism could not be defined by a specific set of symptoms or 
severity (CDC, 2018). Symptoms range from communicational and social deficits and 
repetitive behaviors, such as a child not responding when their name is called, avoiding eye 
contact, or trouble adapting to routine changes (CDC, 2018). The prevalence of ASD is 
currently estimated at 1 in 59 United States children, affecting approximately 4 times as 
many males as females (Baio, Wiggins, & Christensen, 2018). The causes of ASD are still 
unknown, but it is hypothesized to have moderate genetic heritability in combination with 
environmental factors (Hallmayer, et al., 2011). 
Autism among Hispanic people 
 White non-Hispanic children have ASD prevalence rates 1.2x higher than Hispanic 
children Invalid source specified.. While genetics and environmental exposures have not 
been excluded as possible causes for the disparity, the most likely cause is underdiagnosis of 
ASD in Hispanic children (Palmer, Walker, Mandell, Bayles, & Miller, 2010). Hispanic 
families are more likely to be of lower socioeconomic status and lack health insurance or 
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financial resources to seek medical attention (Palmer, Walker, Mandell, Bayles, & Miller, 
2010). Outside of economic determinants however, gaps in education and cultural differences 
may additionally contribute to the underdiagnosis of autism spectrum disorder in Hispanic 
children (Zuckerman, et al., 2017) (Ijalba, 2016).  
 In one study, Latinos with limited English proficiency disproportionately experienced 
barriers to seeking ASD diagnosis and treatment compared to Non-Latino Whites and 
Latinos with English proficiency (Zuckerman, et al., 2017). While all study groups reported 
the barrier “stress of the diagnostic process” most frequently, “parent knowledge about ASD” 
was the most common barrier in Latino families regardless of English proficiency. “Parent 
trust in providers” was a statistically significant more common barrier among Latinos with 
limited English proficiency than in Non-Latino Whites (Zuckerman, et al., 2017). This study 
demonstrates that English proficiency is a crucial indicator of overcoming barriers to seeking 
ASD diagnosis and treatment.  
Several studies have found a lower level of trust in health institutions by racial/ethnic 
minority groups, specifically African Americans and Hispanic Americans, compared to Non-
Hispanic Whites (Schwei, Kadunc, Nguyen, & Jacobs, 2014). Hispanics are three times as 
likely as non-Hispanic whites to lack a regular health care provider and 83% of Hispanic 
participants reported obtaining health information from media, with television being the 
dominant source (Pew Research Center, 2008). Some reasons for health institution distrust by 
Hispanics include a distrust in Western medicine, lack of cultural competency by medical 
providers, and fear of judgement by medical providers towards Hispanic culture and lifestyle 
(Julliard, et al., 2008). Zuckerman et al. stated, “families with higher maternal education and 
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ASD knowledge have better access to ASD care regardless of ethnicity”. However, many 
Hispanic families originate from other countries with little awareness of ASD or few 
resources devoted to children with disabilities (Ijalba, 2016).  A study found that all fourteen 
Hispanic mothers of children with ASD believed their child’s condition was temporary 
(Ijalba, 2016). Therefore, a history of little ASD education combined with general distrust in 
Western providers contribute as barriers to seeking ASD diagnosis and treatment (Ijalba, 
2016) (Zuckerman, et al., 2017) (Julliard, et al., 2008).  
 Additionally, cultural beliefs in the Hispanic community are believed to play an 
important role in the underdiagnoses of ASD in children, as evidenced in the Ijalba study that 
interviewed fourteen Hispanic mothers of children with ASD (Ijalba, 2016). The Hispanic 
community has a very strong relationship with the Catholic faith, and for this reason many 
mothers in the study relied on their faith or divine intervention to cure their child rather than 
seeking medical attention (Ijalba, 2016). Other Hispanic beliefs, such as susto and familismo, 
played roles in a mother not seeking treatment for her child. Susto is the Mexican belief that 
an acute traumatic or fearful event can cause illness (Ijalba, 2016). While a susto event can 
be obvious and physical, other events may be apparent only to the child. In the Ijalba study, 
four out of fourteen mothers reported believing an event of susto caused their child’s ASD, 
with the results being immediate. One mother describes that her 18-month-old was 
developing normally until one day, “Suddenly, he turned to the window and saw something, 
he covered his eyes and cried and would not stop” (Ijalba, 2016). Upon waking up the next 
day, the child did not speak anymore and would eventually be diagnosed with ASD (Ijalba, 
2016). Familismo is a defined as “the strong sense of interdependency and shared decision 
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making in many Hispanic families” and is an important cultural norm in many Hispanic 
communities (Ijalba, 2016). Mothers of children with ASD sought the advice of family 
members, such as grandmothers, who would assure that the child comes from a family 
history of delayed speech or insist that the mother wait longer before seeking professional 
attention. In the study, seven of the fourteen interviewed mothers were advised that “children 
can be late with language” or “father was a late talker” by family members (Ijalba, 2016).  
 Language barriers, lack of ASD education, and cultural beliefs all play a role in 
preventing Hispanic mothers from seeking medical attention for their child with ASD (Ijalba, 
2016) (Zuckerman, et al., 2017). We will now delve into a hypothesis concerning the 
biological pathway maternal inflammation may play a role in ASD development in the child.  
Maternal Inflammation 
Maternal infection during gestation is a known risk factor for autism and has also 
been linked as a risk factor to other neurological disorders such as schizophrenia and cerebral 
palsy (Patterson, Immune involvement in schizophrenia and autism: Etiology, pathology and 
animal models, 2008). A proposed mechanism is that a maternal immune response to 
infection causes an elevation of pro-inflammatory cytokines, which activate a fetal 
inflammatory response that may interrupt proper neurodevelopment (Burd, Balakrishnan, & 
Kannan, 2012). Because the fetal immune system is underdeveloped and vulnerable to 
infection, the fetus begins gestation with an increased concentration of inflammatory proteins 
for protection that decrease with gestational age (Burd, Balakrishnan, & Kannan, 2012). Any 
imbalance of these inflammatory proteins could play a role in injuring a developing brain 
(Burd, Balakrishnan, & Kannan, 2012).  
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Scientists have identified key indicators of immune dysregulation in the brains of 
children with autism, including upregulation of cytokines and activated microglia and 
astrocytes. These indicators are found in the brains of children, suggesting an early initiation, 
as well as adult brains, which suggests a permanent state (Burd, Balakrishnan, & Kannan, 
2012). Cytokines possibly act on the fetus through three different pathways: transplacental 
passage of maternal cytokines, placental production and secretion of cytokines, or fetal 
production of cytokines (Burd, Balakrishnan, & Kannan, 2012). Animal experiments have 
been able to demonstrate the effects of a “maternal inflammation risk factor” with cytokine 
releasing treatments that activate an immune response in mice, even in the absence of a 
pathogen (Patterson, 2011). Offspring of activated mice exhibited behavioral abnormalities 
consistent with ASD, including deficits in communication social interaction and elevated 
anxiety (Patterson, 2011). 
The specific cytokine responsible is still in question. Increased levels of the cytokine 
IFN-γ were noted in the midgestational serum of mothers of children with ASD, with a 50% 
increased risk per one-unit increase (on the natural log scale) for development of ASD 
relative to typically developing controls. IFN-γ is involved in defense against intracellular 
pathogens, auto-immunity, and allergy (Goines, et al., 2011). This is consistent with studies 
that associate higher incidence of allergies and autoimmune diseases in mothers of children 
with ASD than mothers of typically developing children (Croen, Grether, & Yoshida, 2005). 
Peripheral IFN-γ levels are typically low in healthy pregnancies, and elevated levels have 
been associated with complications such as preeclampsia (Goines, et al., 2011). Additionally, 
a maternal immune response could activate the signaling pathway for IL-6, which is one of 
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few cytokines that may cross the placenta and strongly affect fetal development (Patterson, 
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models, 
2008). Injection of IL-6 alone into mice is enough to generate abnormal behaviors and 
changes in brain expression in offspring (Patterson, 2011). Conversely, development of these 
behaviors is prevented when IL-6 is blocked during maternal immune activation, suggesting 
direct correlation between IL-6 expression and behaviors similar to ASD (Patterson, 2011).  
Regardless of which cytokine is directly responsible for ASD in offspring, there are 
several proposed pathways of action causing injury to neural cells (Burd, Balakrishnan, & 
Kannan, 2012). Probable mechanisms by pro-inflammatory cytokines may include direct 
injury to oligodendrocytes and neurons, secondary injury through activation of microglial 
cells, or a combination of both direct and secondary injury (Burd, Balakrishnan, & Kannan, 
2012). Burd et al. created a diagram demonstrating possible mechanisms of fetal brain injury 
in response to maternal inflammation (Figure 1). 
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Figure 1: Possible mechanisms for fetal brain injury by maternal inflammation (Burd, 
Balakrishnan, & Kannan, 2012) 
 
 
Public Health Significance 
Autism spectrum disorder is currently considered one of the most common child 
morbidities (Wang, Geng, Liu, & Zhang, 2017). The public costs of supporting individuals 
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with ASD are a multi-billion-dollar endeavor (Buescher, Cidav, & Knapp, 2014). The cost of 
supporting a child with ASD during his or her lifespan in the United States is $2.4 million if 
the child has an intellectual disability and $1.4 million if the child is without intellectual 
disability (Buescher, Cidav, & Knapp, 2014). The largest cost components for children were 
special education services and parental productivity loss (Buescher, Cidav, & Knapp, 2014). 
Assuming 40% prevalence of intellectual disability in children with ASD, the aggregate 
national cost in the United States is $61 billion per year (Buescher, Cidav, & Knapp, 2014). 
When calculating for adulthood, the highest cost components were supporting living 
accommodations and individual productivity loss. Assuming 40% prevalence of intellectual 
disability in adults with ASD, the aggregate national cost is $175 billion per year in the 
United States (Buescher, Cidav, & Knapp, 2014). Medical bills to care for adults with ASD 
were higher than for children with ASD (Buescher, Cidav, & Knapp, 2014).  
The causes and consequences of ASD in Hispanic populations in the United States is 
incompletely understood. However, the previously discussed literature about the potential 
impacts of commonly held cultural beliefs in many Hispanic communities on knowledge 
about ASD and distrust of medical professionals warrants further study (Ijalba, 2016) 
(Schwei, Kadunc, Nguyen, & Jacobs, 2014). More specifically, the border communities that 
reside on the Texas/Mexico border suffer from lack of access to quality healthcare. The PCP 
to patient ratios in Hidalgo County and Cameron County of the Rio Grande Valley are 
2,230:1 and 2,200:1, respectively, while the state average is 1,670:1. Both counties have 
uninsured rates of 30% (Torres, 2018).  Additionally, Hispanic mothers often turn to family 
or cultural beliefs before seeking professional medical attention when their child exhibits 
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behaviors that are consistent with early signs of ASD (Ijalba, 2016). The investigation of 
prenatal risk factors for ASD among Hispanic mothers are needed to understand the public 
health burden of ASD in border communities – including potentially unique risk factors. 
Research Objectives 
In 2008, the autism prevalence rate was 1 in 88 children. In 2010 and 2012, the rates 
increased to 1 in 68 and 1 in 69 children, respectively. The most recent 2014 data suggests an 
autism prevalence of 1 in 59 children (CDC, 2019). Research towards identification of ASD 
has improved the accuracy of diagnosis; however, further research of prevention and 
identification of risk factors in pregnant Hispanic women is lacking. The overall goal of this 
research is to identify prenatal risk that could impact the risk of ASD in Hispanic children on 
the Texas/Mexico border of children between the ages of 2-21 years old at time of the study. 
Specifically, we aimed to: 
1. Identify prenatal risk factors of ASD by comparing Hispanic women who 
gave birth to children with ASD and Hispanic women who gave birth to 
typically developing children 
2. Compare the prevalence of prenatal risk factors of maternal illnesses and 
maternal medications taken during gestation among Hispanic women living 
on the border to the general population 
3. Investigate effects of maternal inflammation on risk of giving birth to a child 
with ASD 
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METHODS 
Study Design 
 We completed a secondary analysis of data previously collected from a case control 
study of 25 cases and 25 controls. Ideally, we would have gathered data from a greater 
number of participants; however, funding limitations necessitated capping the recruitment of 
this initial pilot study. 
Study Setting 
 The Rio Grande Valley of southern Texas is 90% Hispanic and borders Mexico, 
making it an ideal location to conduct this preliminary study (U.S. Census, 2017). The 
Hispanic Autism Research Center (HARC) sought to identify environmental exposure and 
prenatal risk factors in Hispanic children or their biological mothers that could cause ASD in 
the children (Palmer, 2014). The HARC pilot study was conducted by The University of 
Texas Rio Grande Valley (UTRGV).  
Study Subjects 
Eligibility Criteria 
Inclusion criteria for all child participants included: (a) a child between the ages of 2-
21 years old; (b) living with at least one biological parent; (c) has a parent who speaks 
English or Spanish; (d) residing in the study catchment areas of Harlingen and Brownsville, 
Texas, covering Hidalgo and Cameron counties, or no more than a 2-hour drive from these 
assessment sites (e) of Mexican American ethnicity (Palmer, 2014). Mexican American 
ethnicity was determined by the San Antonio Heart Study (SAHS) algorithm, a nine-item 
indicator which uses parental surnames, birthplace of both parents, self-declared ethnic 
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identity, and ethnic background of grandparents (Palmer, 2014). Inclusion for parent 
participants included: (a) biological parent to a child between the ages of 2-21 years old; (b) 
living with the participant child; (c) parent who speaks English or Spanish; (d) residing in the 
study catchment areas of Harlingen and Brownsville, Texas, covering Hidalgo and Cameron 
counties, or no more than a 2-hour drive from these assessment sites (e) of Mexican 
American ethnicity (Palmer, 2014). 
Children in the case group were children with a clinical diagnosis of Autism 
Spectrum Disorder, including Autism, Asperger’s, and Pervasive Developmental Disorder 
Not Otherwise Specified (PDD-NOS) (Palmer, 2014). Adults in the case group were the 
biological parents of participating children in the case group. Children in the control group 
were typically developing children sampled from the general population. Adults in the 
control group were the biological parents of participating children in the control group. 
Exclusion criteria for cases were children or parents of children diagnosed with other 
neurological disabilities or are non-Mexican American. Exclusion criteria for controls were 
children or parents of children who do not have a clinical diagnosis of ASD or are non-
Mexican American (Palmer, 2014). Due to budgetary restraints, we were unable to match 
controls based on age and gender to cases. For the purposes of this pilot study, 25 cases and 
25 controls were recruited. 
Recruitment 
Multiple organizations participated in the recruitment, including an organization of 
community healthcare workers called Promotoras de Salud and The Easter Seals of the 
Lower Rio Grande Valley (Palmer, 2014). The connections Promotoras de Salud had with 
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school districts, faith-based entities, and other community-based organizations were useful 
tools in recruitment for this study because the promotoras had established a high level of 
trust and reached out to families personally through home visits and phone calls. Recruitment 
also relied heavily on the McAllen and Harlingen centers of The Easter Seals of the Rio 
Grande Valley, referrals, and advertisement (Palmer, 2014). The potential subject’s parent(s) 
responded to advertisements or referrals from local healthcare providers (community 
partners), including Promotoras de Salud and Easter Seals. Research staff then coordinated 
recruitment (Palmer, 2014). 
The research personnel conducted the screening process over the phone and/or in 
person in a private setting (Palmer, 2014). Study coordinators used a standardized script to 
determine eligibility, and research personnel verified that each participant met the eligibility 
criteria (Palmer, 2014). If the participant met initial eligibility criteria, the participant was 
scheduled complete the questionnaire (Palmer, 2014).   
Consent Process 
After the initial phone screen and if the family agrees to further participation, a 
research visit was scheduled at the Clinical Research Unit (CRU) (Palmer, 2014). A 
description of the study was provided verbally and in written form (Palmer, 2014).  Any 
questions the participants had were answered at the time.  Research coordinator or study staff 
guided the family through the protocol (Palmer, 2014). 
All participants signed a form authorizing research to use Protected Health 
Information (PHI)/Private identifiable information (Palmer, 2014). PHI was collected during 
screening for eligibility. All participants signed a consent form and a HIPPA Waiver after 
13 
 
reading detailed risks, benefits, alternatives, and compensation from the research (Palmer, 
2014). Study staff obtained written informed consent at the first research meeting before 
surveys were administered.   
Adequate timing was given to parent(s) to consult with family members to obtain 
consent (Palmer, 2014). Research team members asked the parent(s) to repeat back what it is 
they were consenting to and the research team determined if they were able to understand the 
project well enough to consent (Palmer, 2014). After explaining the goals of the study 
protocol in-person to parent(s), those who could not explain in their own words the purpose 
of the study were deemed unable to provide consent, and their child was not enrolled 
(Palmer, 2014). The same process took place for Spanish speaking individuals to ensure 
comprehension among both languages. 
Participants were compensated with $150 upon completion of the study in addition to 
a $50 travel allowance (Palmer, 2014). The study was at no cost to the participant. 
Data Handling and Record Keeping 
 All surveys are stored in a locked repository at The University of Texas Rio Grande 
Valley (UTRGV) Harlingen Clinical Education Building, 2102 Treasure Hills Boulevard, 
Harlingen, TX 78550 (Palmer, 2014). The Principal Investigator (Beatriz Tapia, MD, MPH, 
EdD) is responsible for the repository (Palmer, 2014). Other researchers requesting 
information from the repository must have the approval of the PI (Palmer, 2014). Data 
remains on paper surveys in the repository until coded into Microsoft Excel. All electronic 
documents containing survey data are saved on a password-protected flash drive. 
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 Each survey was labeled with respondent’s unique study ID. The code linking ID 
numbers to other personal identifying information is kept in a locked file cabinet, and in 
electronic files that do not contain any other information and do not exist on computers 
containing any other information about the participants. 
Data Collection and Abstraction 
 The thirteen-part survey was created to evaluate environmental causes and prenatal 
risk factors and administered in-person to participating mothers (Figure 2). Participants 
scheduled a time to take the survey with a member of the research team present (Palmer, 
2014). Surveys were administered in-person by a member of the research team between July 
2011 and August 2014. The questionnaire took approximately 2-3 hours per participant and 
administration was conducted in private room at the Clinical Research Unit (CRU). All 
survey answers were written by the mothers onto the survey, and research personnel were 
available for clarification of questions. Data was recorded on paper and transferred to 
Microsoft Excel for coding and analysis.  
 Abstraction of recorded survey answers from paper to Microsoft Excel included 
coding for multiple choice and free response answers. Coding keys for data abstraction are 
described in an accompanying codebook. The standard coding for close ended answers are: 
1 yes 
0  no 
996 refuse to answer 
997 don't know 
998 cannot code or missing 
999 not applicable 
15 
 
 Open ended answers were transferred directly into Excel as they were written into the 
survey. 
Data Analysis 
 Part 7 of the survey pertains to questions concerning “Maternal Illness, Medications, 
and Procedures during Pregnancy”. Data from Part 7 was used to test prenatal risk factors. 
Specifically, we investigated the association between maternal illnesses and medications 
during pregnancy and ASD. We assessed differences in prevalence of prenatal risk factors 
were between case mothers and control mothers. Because of the small sample size, all 
statistical tests were non-parametric. All analysis was conducted using STATA 15.  
Human Subjects, Animal Subjects, or Safety Considerations  
This study is a secondary analysis of data that has already been collected. This study 
involves human subjects and is therefore subject to the Committee for Protection of Human 
Subjects. Participants have the right to refuse to participate in any aspect of the study or to 
withdraw from the study at any time. All survey data was deidentified, so the risk to humans 
physically/mentally is minimal. This study has been approved by the IRB. 
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Figure 2: Index of survey provided to participant mothers concerning environmental and 
prenatal risk factors for ASD in the child 
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RESULTS 
Characteristics of Study Cohort 
Demographics of known risk factors include maternal age at conception of index 
child, and sex, birth weight, and gestational age of index child (Table 1). Average age of 
conception of index child in case mothers was 29.01 with standard deviation of 6.56 and 
overall range of 17.6 to 43.9 years. Average age of conception of index child in control 
mothers was 27.36 with standard deviation of 6.71 and overall range of 16.9 to 38.9 years. 
Males constituted 96% of case children and 72% of control children. Average birth weight of 
case children was 109.75 ounces with standard deviation of 20.81 and overall range 70 to 
152 ounces, whereas average birthweight in control children was 115.8 ounces with standard 
deviation 13.93 and overall range of 92 to 136 ounces. Average gestational age was 37.44 
weeks for case children, standard deviation 2.04 and overall range 32 to 40 weeks, and 39.3 
weeks for control children, standard deviation 1.12 and overall range 37 to 42 weeks. Due to 
limited funding, cases and controls were not matched. 
There were no meaningful differences between the age at conception or birth weight 
of cases and controls. A Wilcoxon rank sum was executed for age at conception, birth 
weight, and gestational age because the data was nonparametric. Wilcoxon rank sum 
indicated no difference in the median ages of conception between case and control mothers, 
28.89 and 25.74 years, respectively (p = 0.432). There was no meaningful differences 
between the medians of birthweight between cases and controls, 107 and 121 ounces, 
respectively (p = 0.2002).  
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The proportion of male cases was larger than male controls (two-tailed p: 0.0206; 
one-tailed p: 0.0103), which is consistent with research reflecting autism rates affecting 
males 4 times higher than females (Baio, Wiggins, & Christensen, 2018). Wilcoxon rank sum 
indicated a difference in gestational age medians of cases and controls, 38 and 40 weeks, 
respectively (p = 0.0004). 
Table 1: Descriptive statistics of known risk factors for mothers and index children 
 
Variables Cases (n=25), sd Controls (n=25), sd P-value 
Mother   
 
Age at Conception (years) 29.01, 6.56 27.36, 6.71 0.432 
Index Child   
 
Sex (percentage, male) 96, - 72, - 0.0206 
Birth Weight (ounces) 109.75, 20.81 115.8, 13.93 0.2002 
Gestational Age (weeks) 37.28, 2.04 39.3, 1.12 0.0004 
    
 
Prevalence of Risk Factors 
Two separate categories of prenatal risk factors were analyzed: maternal illness 
during pregnancy and medications taken during pregnancy. The maternal illnesses surveyed 
were urinary tract infections (UTIs), migraines, allergies, vaginal bleeding, and physical 
injury. Mothers reported whether they experienced any of the illness at any point during 
index pregnancy (Table 2) (Figure 2). All illnesses were reported more often in cases than 
controls. 
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Table 2: Differences in prevalence (counts) of reported maternal illnesses during gestation 
of index pregnancy 
 
Maternal Illnesses
Count of Cases 
(n=25)
Count of Controls 
(n=25)
Fisher's 
exact
Urinary tract infections (UTIs) 10 2 0.018
Migraines 6 3 0.463
Allergies 10 3 0.051
Vaginal bleeding 9 2 0.037
Physical injury 6 4 0.496
 
Figure 3: Reported maternal illnesses during gestation of index pregnancy  
 
Mothers also reported whether they took any of the following medications or 
medications for ailments at least once during their index pregnancy: Tylenol, antibiotics of 
any kind, ibuprofen, allergy medication, pain medication, and cold medication (Table 3). All 
medications were reported more often in cases than controls. 
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Table 3: Differences in prevalence (counts) of reported maternal medications taken during 
gestation of index pregnancy 
 
Maternal Medications
Count of Cases 
(n=25)
Count of Controls 
(n=25)
Fisher's 
exact
Tylenol 14 10 0.396
Antibiotics 7 2 0.138
Ibuprofen 7 2 0.138
Allergy medications 7 2 0.138
Pain medications 11 6 0.232
Cold medications 7 2 0.138  
Figure 4: Reported maternal medications taken during gestation of index pregnancy 
 
Measures of Association concerning Prevalence 
 Odds ratios were calculated conducted to measure the association between the 
individual maternal illnesses and ASD (Table 4) and maternal medications and ASD (Table 
5).   
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Table 4: Odds ratios of reported maternal illnesses during gestation of index pregnancy 
 
Maternal illnesses reported 
during gestation Odds ratio 
95% Confidence 
Interval p-value 
Urinary tract infections (UTIs) 7.667 [1.470, 39.987] 0.008 
Migraines 2.316 [.509, 10.543] 0.270 
Allergies 4.889 [1.150, 20.790] 0.024 
Vaginal bleeding 6.469 [1.230, 34.011] 0.017 
Injury 1.750 [.426, 7.190] 0.435 
 
Table 5: Odds ratios of reported maternal medications taken during gestation of index 
pregnancy 
 
Maternal medications reported 
taken during gestation 
Odds 
ratio 
95% Confidence 
Interval p-value 
Tylenol 1.909 [.620, 5.876] 0.258 
Antibiotics 4.472 [.827, 24.193] 0.066 
Ibuprofen 4.472 [.827, 24.193] 0.066 
Allergy medications 4.472 [.827, 24.193] 0.066 
Pain medications 2.488 [.741, 8.350] 0.136 
Cold medications 4.472 [.827, 24.193] 0.066 
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DISCUSSION 
 The authors of this study acknowledge that the small sample size (n = 25) reduces the 
power of the study, and thereby the ability to detect meaningful differences between the two 
groups. However, a comprehensive view of statistical significance, point estimates, and 
confidence intervals can provide meaningful implications of the results. 
 While all illnesses were reported more often in cases than controls, meaningful 
differences in counts were calculated through Chi-squared analysis of vaginal bleeding and 
UTIs (Table 2). This is corroborated by confidence intervals indicating a positive association 
between vaginal bleedings, UTIs, and ASD in the child (Table 4). The confidence intervals 
are extremely wide, indicating a lack of precision in the point estimate and low statistical 
quality. However, the high upper limits of the confidence intervals and positive association 
of the exposure to the outcome could provide clinical or practical implications that UTIs and 
vaginal bleeding are potential prenatal risk factors to further investigate. These implications 
can also be applied to the other illnesses that were not evaluated to be statistically significant 
by p-values or confidence intervals. Point estimates of all maternal illnesses were positive, 
indicating a general positive association between the prenatal risk factors and the outcome of 
ASD. 
Urinary tract infections (UTIs) 
 
The odds of ASD in the index child are 7.667 times greater when born to mothers 
who experienced UTIs during gestation of the child than those who did not (CI: [1.470, 
37.987], p = 0.008) (Table 4). Previous case-control studies investigating the risk between 
maternal infections during pregnancy and risk of ASD found a mild, but significant 
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association between maternal bacterial infections in the second trimester and ASD. Overall, 
women with bacterial infections diagnosed during hospital admissions were at increased risk 
of delivering a child with ASD (ORadj: 1.58; 95% CI: 1.06-2.37). Genitourinary infections 
were one of the most commonly diagnosed infections during pregnancy, with UTIs being 
among the most common of the genitourinary type. Bacterial infections during pregnancy in 
the second and third trimesters were also associated with a moderately increased ASD risk. 
UTIs were the most common bacterial infections in the third trimester (Zerbo, et al., 2016). 
Vaginal Bleeding 
The odds of ASD in the index child are 6.469 times greater when born to mothers 
who experienced vaginal bleeding during gestation of the child than those who did not (CI: 
[1.230, 34.012], p = 0.017) (Table 4). Increased prevalence of vaginal bleeding in this study 
is consistent with past peer-reviewed studies of prenatal factors, which found that 16.7% of 
case mothers experienced vaginal bleeding. This was significantly higher than the national 
rate of gestational vaginal bleeding of 6.6% (p = 0.001) (Brimacombe, Ming, & Lamendola, 
2007). In this study, 36% of case mothers experienced vaginal bleeding and the most recent 
rate for the state of Texas is 20.8% (PRAMS, 2011).  
Allergies 
 
The odds of ASD in the index child are 4.889 times greater when born to mothers 
who experienced allergies during gestation of the child than those who did not (CI: [1.150, 
20.790], p = 0.024). Ongoing research has attempted to link allergic conditions with 
autoimmune disorders because they are both hypersensitivity responses (Sayed, Christy, 
Quirion, & Brown, 2008). One study found elevated ASD risk for maternal allergy diagnoses 
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during the second trimester of pregnancy (ORadj: 2.5, 95% CI: 1.2 – 5.2) (Croen, Grether, & 
Yoshida, 2005). 
Maternal medications 
 
 Statistically, no maternal medications demonstrated significant difference in 
prevalence counts or point estimates. However, all point estimates were positive and the 
upper limit of the confidence intervals were high (ranging from 8.35 to 24.193, Table 5). 
Prior studies strongly suggest a relationship between medication mechanism and autism 
development, specifically Tylenol. While acetaminophen (Tylenol) is typically used to 
reduce inflammation, studies show that even low doses of the drug can induce immune 
system activation and oxidative stress responses associated with autism development (Parker, 
et al., 2017).  
An additional evaluation elicited from this study is that maternal illnesses and 
maternal medications were more frequently reported across all variables in case mothers. 
While this may be a result of recall bias, it may also indicate behavioral patterns of frequent 
illness or medication consumption in mothers who will give birth to children with autism. 
Limitations 
One major limitation of this pilot study is its small sample size. Because this is a pilot 
study, the researchers only had enough funding for 25 cases and 25 controls. Subsequently, 
the small sample size may not provide enough statistical power to detect significant results in 
variables measured. In future research, the power could be improved by adjusting the type I 
error level to reflect the sample size and variability of the data. Another way to improve 
power is increasing the sample size with increased funding and greater recruiting. 
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Another consequence of limited funding and small sample size is that confounders 
could not be addressed. The author is aware there are many variables that may ask as 
confounders to autism risk, including but not limited to: infant sex, infant birth weight, and 
maternal age at conception (Goines, et al., 2011). Frequency matching for these variables 
was not economically feasible, and the sample size was too small for logistic regression. 
This study only measured occurrence of prenatal risk factors and did not delve deeper 
into timing of the infection. As critical as timing is in fetal development, it would be prudent 
to accurately identify the timing of the symptoms as way of identifying which point in the 
gestational pathway maternal inflammation is most potent.  
Lastly, all data was self-reported by the mothers retroactively and is subject to recall 
bias. Survey responses were not cross-referenced with medical records due to lack of 
funding, so all data is reliant on maternal recall.  
Strengths 
The results of our analysis of data collected in this preliminary pilot study are 
consistent with the idea that maternal inflammation increases risk for autism in the child. 
Additionally, we found meaningful differences in prevalence and odds of vaginal bleeding, 
UTIs, and allergies during gestation. These trends have also been studied and supported in 
numerous past peer-reviewed studies of larger scale (Brimacombe, Ming, & Lamendola, 
2007) (Zerbo, et al., 2016) (Croen, Grether, & Yoshida, 2005).  
Additionally, this study used a very specific sample of Hispanic women and children 
who live on the Texas/Mexico border. While this group has typically lower diagnosis rates of 
ASD, the data of this small study on a specific group of individuals is consistent with larger 
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studies concerning all races and ethnicities. The finding that prenatal risk factors can 
similarly influence Hispanic women and their children as they do other women and children 
strengthens the idea that the Hispanic children are underdiagnosed and there is not a 
protective genetic component in Hispanics.  
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CONCLUSION 
The current pilot study and past peer-reviewed literature indicate a strong association 
between prenatal risk factors and autism risk in the child. This association is supported by 
research of maternal inflammation and its role in fetal neurodevelopment. As a result, three 
prenatal risk factors were found to have association with ASD should be studied further for 
their role in autism risk: maternal vaginal bleeding, UTIs, and allergies. Early identification 
and treatment of these risk factors during gestation may play a role in reducing ASD risk. 
This research has the potential to significantly impact the health and quality of life of 
Hispanic women and children living on the Texas/Mexico border. This population is 
medically underserved, and as a result autism is underdiagnosed. Identification and 
appropriate treatment of the prenatal risk factors should be taught to local clinicians and 
community health workers. The public health community can use this data to create 
awareness and educate Hispanic women on risk factors to be mindful of while they are 
pregnant.  
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